Unchanged incidence of diabetic nephropathy in Type 1 diabetes: a nation-wide study in Iceland
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2005-02-01
Metadata
Show full item recordCitation
Diabet. Med. 2005, 22(2):182-7Abstract
AIMS: Diabetic nephropathy is an uncommon cause of end-stage renal disease in Iceland in contrast to most industrialized countries. The aim of this study was to examine the incidence of diabetic nephropathy in Iceland. METHODS: All patients diagnosed with Type 1 diabetes in Iceland before 1992 were studied retrospectively. Patients diagnosed before age 30, who were insulin dependent from the onset, were defined as having Type 1 diabetes. Diabetic nephropathy was defined as persistent proteinuria measured with a dipstick test (Albustix) on three consecutive clinic visits at least 2 months apart. Patients were followed to the end of year 1998, to their last recorded outpatient visit, or until death. The cumulative incidence of diabetic nephropathy was calculated with the Kaplan-Meier method and presented according to the duration of diabetes divided into 5-year intervals. RESULTS: A total of 343 patients with Type 1 diabetes were identified. The mean follow-up period was 20.2 +/- 11.4 (mean +/- sd) years. Only 9.3% of patients were lost to follow-up. Sixty-five patients developed diabetic nephropathy. The cumulative incidence was 22.6% at 20 years and levelled off at 40.3% after approximately 35 years of diabetes duration. No significant changes in cumulative incidence were observed over time. Mean glycated haemoglobin was 8.4% in patients with proteinuria and 7.8% in a group of patients without proteinuria that was matched for age, gender and duration of diabetes (P = 0.04). CONCLUSIONS: The cumulative incidence of diabetic nephropathy in Iceland is comparable with previously reported cumulative incidence rates and has remained unchanged. Glycaemic control was significantly better in patients without proteinuria.Description
To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldae974a485f413a2113503eed53cd6c53
10.1111/j.1464-5491.2004.01390.x
Scopus Count
Collections
Related articles
- [Diabetic nephropathy. Unchanged occurrence in patients with insulin-dependent diabetes mellitus].
- Authors: Rossing P, Rossing K, Jacobsen P, Parving HH
- Issue date: 1996 Oct 14
- Declining incidence of nephropathy in insulin-dependent diabetes mellitus.
- Authors: Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J
- Issue date: 1994 Jan 6
- Time trends in the epidemiology of renal transplant patients with type 1 diabetes mellitus over the last four decades.
- Authors: Cao C, Hellermann JP, Weber M, Ambühl PM
- Issue date: 2006 Mar
- [Has the incidence of end-stage renal disease increased in diabetic patients? A center-based longitudinal study over 10 years].
- Authors: Van Landeghem MA
- Issue date: 2005 May 13
- Diabetic macular edema and its relationship to renal microangiopathy: a sample of Type I diabetes mellitus patients in a 15-year follow-up study.
- Authors: Romero P, Baget M, Mendez I, Fernández J, Salvat M, Martinez I
- Issue date: 2007 May-Jun